Only 1 out of 5 generally healthy patients were found at risk for rare genetic diseases following whole-genome sequencing, a study showed
As the volume of biodata grows exponentially, organizations are only now finding ways to extract the value found in these massive data sets
This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
Swati Ranade, Ph.D.
Senior Manager, PacBio